Herbert Loong

Herbert Loong: Discussing the Role of Selective RET Inhibitors in NSCLC

Herbert Loong, Chair-Elect of the International Affairs Committee and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), shared a post on X:

“Thanks Herdee Luna, Roselle De Guzman and other thoracic oncology colleagues from Philippines for your wonderful invite and hospitality as we discussed role of selective RETinhibitors, importance of moleculartesting in nsclc and beyond.”

Herbert Loong